Employee-related Liabilities, Current of ELITE PHARMACEUTICALS INC /NV/ from 30 Jun 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Employee-related Liabilities, Current in USD history and change rate from 30 Jun 2023 to 31 Mar 2024.
  • ELITE PHARMACEUTICALS INC /NV/ Employee-related Liabilities, Current for the quarter ending 31 Mar 2024 was $206,225.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $206,225 31 Mar 2024 10-K 01 Jul 2024 2024 FY
Q4 2023 $712,384 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $494,315 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 $30,000 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.